Vaccine researchers working in the lab

Working at the interface between clinician-scientists, healthcare workers, basic scientists and modellers, we drive programs of research from bench to bedside and bedside to bench. We translate research into interventions to improve health, using clinical samples to gain more understandings about health and disease. We take discoveries made in immunology, cell biology, and molecular biology, often derived from clinical samples, and build on these to develop interventions and human clinical trials.

Through basic discovery science we identify the causes of disease and characterise novel pathogens. Our multidisciplinary approach drives progress in the development of vaccines, therapeutics, and diagnostics through human clinical trials.

Our clinical & health sciences champions

  • Professor Wendy Barclay

    Professor Wendy Barclay

    Personal details

    Professor Wendy Barclay Action Medical Research Chair Virology, Head of Department of Infectious Disease

    Research interests

    Respiratory viruses, in particular influenza and, most recently, SARS-CoV-2. Studies in the lab aim to understand the molecular and cellular basis of the pathogenesis, host range restrictions and viral transmissibility using genetic techniques to generate recombinant viruses and human airway models.

  • Dr Lauren Cator

    Dr Lauren Cator

    Personal details

    Dr Lauren Cator Senior Lecturer, Department of Life Sciences

    Research interests

    Using laboratory and field experiments to understand mosquito behavioural ecology in order to improve the control of the diseases they transmit. Current work focuses on behavioural aspects of reproduction, host-parasite interactions, and the response of mosquito populations to land-use change.

  • Dr Abigail Clements

    Dr Abigail Clements

    Personal details

    Dr Abigail Clements Lecturer - Department of Life Sciences

    Research interests

    Bacterial pathogenesis, in particular enteric pathogens Shigella, E. coli and emerging nosocomial pathogen Klebsiella pneumoniae . Comparing molecular mechanisms used by these pathogens to establish host infection using a combination of genetic, biochemical, bioinformatic and cell-based techniques.

  • Dr Céire Costelloe

    Dr Ceire Costelloe

    Personal details

    Dr Céire Costelloe Senior Lecturer and Director of Global Digital Health Unit

    Research interests

    Addressing key questions in infection-related and antimicrobial-resistant infection (AMR), in particular evaluating interventions targeting AMR using routinely collected clinical data and novel statistical causal inference methods.

  • Professor Sarah Fidler

    Professor Sarah Fidler

    Personal details

    Professor Sarah Fidler Professor of HIV and Communicable Diseases

    Research interests

    Professor Sarah Fidler is a clinical academic who provides care for people living with HIV. Her main research interest is in the diagnosis, treatment and cure of HIV infection.

  • Professor Michael Levin

    Professor Michael Levin

    Personal details

    Professor Michael Levin Chair in Paediatrics & International Child Health

    Research interests

    Diagnosis and treatment of a range of childhood infections including meningococcal disease, tuberculosis, bacterial sepsis and Kawasaki disease. Currently leads the EU funded DIAMOND study investigating the application of RNA transcriptomics to improve diagnosis of childhood infection.

  • Professor Peter Openshaw

    Professor Peter Openshaw

    Personal details

    Professor Peter Openshaw Senior Consul, Professor of Experimental Medicine

    Research interests

    How the immune system both protects against viral infection but also causes disease. A long-standing interest in RSV, influenza and, most recently, SARS-CoV-2, with his leadership of the PREPARE EU consortium and ISARIC4C collaborative network focussed on COVID in the UK.

  • Professor Faith Osier

    Professor Faith Osier

    Personal details

    Professor Faith Osier Professor of Malaria Immunology

    Research interests

    Vaccine development, with a particular emphasis on malaria. The group uses a myriad of immunological tools for understanding the immuno-epidemiological and immunological characteristics of blood-stage malaria infection and the future development of an anti-disease blood-stage vaccine.

  • Professor Robin Shattock

    Professor Robin Shattock

    Personal details

    Professor Robin Shattock Chair in Mucosal Infection and Immunity

    Research interests

    Leading an international effort to develop an RNA-based COVID-19 vaccine, and researching the mechanisms of mucosal infection to develop novel preventative strategies. This has led to the establishment of international collaborations aimed at preclinical identification, development and selection of HIV microbicide.

  • Dr John Tregoning

    Dr John Tregoning

    Personal details

    Dr John Tregoning Reader in Respiratory Infections

    Research interests

    Developing a range of in vivo and in vitro models of infection and vaccination in early life, including RSV, Influenza, Pseudomonas aeruginosa , Staphylococcus aureus and Acinetobacter baumannii . They are using this approach to develop a broader understanding of respiratory infections and guide the design of vaccines.